Rhenman & Partners Asset Management Ab Boston Scientific Corp Transaction History

Rhenman & Partners Asset Management Ab

$1.2 Billion
Q3 2024

A detailed history of Rhenman & Partners Asset Management Ab transactions in Boston Scientific Corp stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 590,000 shares of BSX stock, worth $52.9 Million. This represents 4.12% of its overall portfolio holdings.

Number of Shares

590,000

Previous 595,000 0.84%

Holding current value

$52.9 Million

Previous $45.8 Million 7.9%

% of portfolio

4.12%

Previous 4.53%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$72.96 - $84.0 $364,799 - $420,000	-5,000 Reduced 0.84%	590,000 $49.4 Million
Q2 2024 Aug 13, 2024	BUY	$67.33 - $77.71 $875,290 - $1.01 Million	13,000 Added 2.23%	595,000 $45.8 Million
Q1 2024 May 14, 2024	SELL	$57.6 - $68.62 $9.68 Million - $11.5 Million	-168,000 Reduced 22.4%	582,000 $39.9 Million
Q4 2023 Feb 13, 2024	BUY	$48.64 - $57.81 $2.43 Million - $2.89 Million	50,000 Added 7.14%	750,000 $43.4 Million
Q3 2023 Nov 13, 2023	BUY	$50.19 - $54.68 $6.02 Million - $6.56 Million	120,000 Added 20.69%	700,000 $37 Million
Q2 2023 Aug 11, 2023	SELL	$49.72 - $54.64 $994,400 - $1.09 Million	-20,000 Reduced 3.33%	580,000 $31.4 Million
Q1 2023 May 11, 2023	BUY	$45.09 - $50.03 $676,350 - $750,450	15,000 Added 2.56%	600,000 $30 Million
Q4 2022 Feb 13, 2023	SELL	$39.56 - $47.22 $4.35 Million - $5.19 Million	-110,000 Reduced 15.83%	585,000 $27.1 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $1.1 Million - $3.29 Million	-30,000 Reduced 4.14%	695,000 $30 Million
Q2 2022 Aug 12, 2022	BUY	$35.24 - $47.1 $7.58 Million - $10.1 Million	215,000 Added 42.16%	725,000 $27 Million
Q1 2022 May 13, 2022	SELL	$40.9 - $45.1 $16.4 Million - $18 Million	-400,000 Reduced 43.96%	510,000 $22.6 Million
Q4 2021 Feb 11, 2022	BUY	$38.07 - $44.87 $12.9 Million - $15.3 Million	340,000 Added 59.65%	910,000 $39.1 Million
Q3 2021 Nov 12, 2021	BUY	$41.23 - $45.88 $2.06 Million - $2.29 Million	50,000 Added 9.62%	570,000 $24.7 Million
Q2 2021 Aug 13, 2021	SELL	$38.58 - $44.24 $5.79 Million - $6.64 Million	-150,000 Reduced 22.39%	520,000 $22.2 Million
Q1 2021 May 14, 2021	BUY	$35.27 - $39.67 $4.94 Million - $5.55 Million	140,000 Added 26.42%	670,000 $25.9 Million
Q4 2020 Jan 19, 2021	BUY	$33.15 - $41.97 $2.65 Million - $3.36 Million	80,000 Added 17.78%	530,000 $19.1 Million
Q3 2020 Oct 13, 2020	BUY	$34.44 - $42.23 $1.38 Million - $1.69 Million	40,000 Added 9.76%	450,000 $17.2 Million
Q2 2020 Jul 16, 2020	SELL	$30.19 - $39.11 $4.68 Million - $6.06 Million	-155,000 Reduced 27.43%	410,000 $14.4 Million
Q1 2020 Apr 16, 2020	BUY	$25.83 - $45.71 $2.93 Million - $5.18 Million	113,332 Added 25.09%	565,000 $18.4 Million
Q4 2019 Jan 17, 2020	BUY	$37.87 - $45.37 $3.09 Million - $3.71 Million	81,668 Added 22.07%	451,668 $20.4 Million
Q3 2019 Oct 16, 2019	SELL	$40.31 - $43.45 $721,871 - $778,102	-17,908 Reduced 4.62%	370,000 $15.1 Million
Q2 2019 Jul 22, 2019	BUY	$34.91 - $42.98 $698,199 - $859,599	20,000 Added 5.44%	387,908 $16.7 Million
Q1 2019 Apr 11, 2019	SELL	$32.91 - $40.75 $329,099 - $407,500	-10,000 Reduced 2.65%	367,908 $14.1 Million
Q4 2018 Feb 05, 2019	BUY	$31.73 - $39.04 $1.27 Million - $1.56 Million	39,940 Added 11.82%	377,908 $13.4 Million
Q3 2018 Oct 03, 2018	SELL	$32.83 - $38.63 $328,300 - $386,300	-10,000 Reduced 2.87%	337,968 $13 Million
Q4 2017 Jan 19, 2018	BUY	$24.79 - $29.8 $1.67 Million - $2.01 Million	67,500 Added 24.07%	347,968 $8.63 Million
Q3 2017 Oct 13, 2017	BUY	$26.26 - $29.17 $7.37 Million - $8.18 Million	280,468	280,468 $8.18 Million

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $128B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account

Rhenman & Partners Asset Management Ab Boston Scientific Corp Transaction History